CompletedNot Applicable

The Effect of Clinical Parameters on Muscle Oxygenation in Patients With COPD

Turkey (Türkiye)41 participantsStarted 2023-04-24

Plain-language summary

The aim of this study is to examine the peripheral muscle oxygenation of patients with Chronic Obstructive Pulmonary Disease at rest, during submaximal exercise and recovery, and to examine the effects of disease severity and respiratory functions on peripheral muscle oxygenations. In this study, the effect of disease severity and respiratory problems on peripheral muscle metabolism of patients with COPD will be explained.

Who can participate

Age range40 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Being diagnosed with COPD (according to GOLD Staging: GOLD 1, GOLD 2, GOLD 3, GOLD 4) * Being between the ages of 40-80 * Body Mass Index \<35 * Not having an acute exacerbation in the last 3 months Exclusion Criteria: * Patients who do not want to participate in the study * Arthritis causing weakness in the lower extremity, neurological disease, deep vein thrombosis, peripheral arterial disease, muscle weakness, fracture etc. patients with the condition * Common diseases such as malignancy, pulmonary embolism, vasculitis, collagen tissue diseases, interstitial fibrosis, severe pneumonia patients with parenchymal destruction * Patients with severe dyspnea and hemodynamic instability who cannot perform the 6 Minute Walk Test

What they're measuring

Muscle oxygenation

Timeframe: one day

Trial details

NCT IDNCT06041126

SponsorBandırma Onyedi Eylül University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-06-23

View on ClinicalTrials.gov More Chronic Obstructive Pulmonary Disease trials